ValueAct Capital and Valeant Pharmaceuticals Legacy

ValueAct Capital's involvement with Valeant Pharmaceuticals is a significant chapter in the firm's history. ValueAct Capital, a hedge fund, invested in Valeant in 2014.

Valeant's stock price skyrocketed after ValueAct's investment. This caught the attention of many investors and analysts.

ValueAct's investment in Valeant was a calculated risk that paid off initially. Valeant's stock price rose significantly after ValueAct's investment.

ValueAct's influence on Valeant's operations and strategy was substantial.

Recommended read: Valueact 13f

ValueAct Capital was initially formed in June 2000 to manage the capital of its founders and a limited number of outside investors. The firm's founding leader was Jeff Ubben, who led it until 2020.

Mason Morfit took over as CEO in 2020 and has been leading the firm since then.

ValueAct Capital is a very active investor that identifies companies that appear to be out of favor or may be undergoing a significant transition. They make a significant investment into the company and then work with the company to make changes with the goal of increasing long-term stock value and thus creating a profit for ValueAct.

You might like: Fareast Islami Life Insurance Company Limited

In August 2020, ValueAct sold all of their stake in Rolls-Royce. They also disclosed a multi-billion stake in Salesforce in January 2022, leading to Salesforce appointing three new directors to the board, including Mason Morfit, CEO and CIO of ValueAct Capital.

ValueAct is known for their significant investments, with a total AUM (Assets Under Management) of $9.8 billion as of 2024-03-28.

Recommended read: Valueact Disney

ValueAct Capital Partners has been making waves in the business world. They're known for working constructively with boards, which is a refreshing approach in the often-contentious world of activist investing.

ValueAct has taken positions in notable companies like Adobe, Citigroup, and Nintendo. They're also pushing The New York Times to sell bundled subscriptions to readers more aggressively.

The investor has also taken a stake in Kohlberg Kravis Roberts, with relations between the two parties being amicable for now.

For another approach, see: Valueact Capital News

ValueAct Capital is a very active investor that identifies companies that appear to be out of favor or may be undergoing a significant transition.

Consider reading: B Capital

They make a significant investment into the company and then work with the company to make changes with the goal of increasing long-term stock value.

In August 2020, ValueAct sold all of its stake capital in Rolls-Royce.

ValueAct disclosed a multi billion stake in Salesforce in January 2022.

On January 27, Salesforce announced that it is appointing three new directors to the board, one of whom is Mason Morfit, CEO and CIO of ValueAct Capital.

Readers also liked: What Does Sofi Do as a Company

ValueAct Capital Management LP is a notable player in the investment world, with a significant presence in the market. They have a total AUM of $9.8 billion as of March 28, 2024.

Their team consists of 42 employees, with 40% being investors and 0% being brokers.

ValueAct Capital Management LP is headquartered in San Francisco, California, and can be reached at 415-362-3700.

They have a range of funds, including the ValueAct Strategic Master Fund II LP, ValueAct Japan Master Fund LP, and ValueAct Capital Master Fund LP.

If this caught your attention, see: Glenview Capital Management

Here are some key statistics on their funds:

Their AUM breakdown by client type shows that they have a significant presence in pooled investment vehicles, with 15 accounts and an AUM of $11.7 billion.

Their limited partners include notable institutions such as the New York State and Local Retirement System and the North Carolina Retirement Services.

ValueAct Capital Management LP has a strong leadership team, with notable directors such as Jeffrey Ubben, G Morfit, and Brandon Boze.

In terms of comparable firms, ValueAct Capital Management LP can be compared to firms such as RWC Asset Management LLP, Capital Fund Management Sa, and Abrams Capital Management LP, which have similar AUM levels.

Take a look at this: Real Estate Asset Management Companies

ValueAct Capital's investment strategy was influenced by the Valeant Pharmaceuticals scandal, which highlighted the dangers of activist hedge funds.

The scandal led to a significant decline in Valeant's stock price, from $254 to $13.95, and a loss of over $80 billion in market value.

ValueAct's experience with Valeant taught them the importance of due diligence and thorough research before making investment decisions.

As a result, ValueAct has developed a more nuanced approach to activism, focusing on long-term value creation rather than short-term gains.

ValueAct's investment in Valeant was a significant factor in the company's decline, as the hedge fund's actions were seen as contributing to the company's financial struggles.

The Valeant scandal also led to increased scrutiny of activist hedge funds, with many calling for greater transparency and accountability.

ValueAct has learned from the Valeant experience and has implemented changes to its investment strategy to avoid similar pitfalls.